Alphaeon buys Physician Recommended Nutriceuticals (PRN) for US$55m

Published: 28-Jul-2014
Finance

Adds omega-3 and related products for dry eye and macular degeneration to portfolio


Alphaeon, a Californian lifestyle healthcare company and subsidiary of equity firm Strathspey Crown Holdings, has acquired Physician Recommended Nutriceuticals (PRN) for US$55m.

Plymouth Meeting, PA, US-based PRN is a developer of specialist omega-3s and related nutraceutical products for dry eye and macular degeneration.

Robert Grant, Chief Executive of Alphaeon, said the deal 'brings together world renowned ophthalmologists and a premier physician recommended line of nutraceutical products that benefit patients'.

Over the past five years, PRN has achieved consistently high double-digit growth over several years, he said.

He added: 'We are very pleased to partner with such a quality organisation and leadership team and look forward to maintaining their stand-alone operation just outside Philadelphia. This acquisition brings significant customer synergies to both organisations and is ideally aligned to Alphaeon's mission to provide best-in-class wellness related products to patients.'

PRN CEO Ken Krieg added that the acquisition is well timed to 'expand the reach of PRN's evidence-based nutraceuticals through Alphaeon's platform of physician selected services and industry leading marketing campaigns'.

Alphaeon will begin offering the omega-3 products from 1 August.

See more

You may also like

Training & Education

dsm-firmenich awards Nutrition Research Grants totalling €250,000 to APAC-based gut health researchers

Read more
The nutrition-focused company will award up to €50,000 to each recipient to advance research on pre-, pro- and postbiotics, as well as human milk oligosaccharides (HMOs) on gut health and overall wellness

Trending Articles

  1. Green Bioactives receives £224,000 to develop its plant metabolite biomanufacturing platform The funding from Innovate UK will allow the company to accelerate the development of its botanical metabolite biomanufacturing platform
  2. Happy Plant Protein secures €1.8m to develop and license its plant-based protein ingredients The manufacturing process developed by Happy Plant Protein can reduce plant-based protein production costs by up to 90%, while also creating functional food products with a 70–80% protein content
  3. TricorBraun acquires Plas-Pak WA to extend Australian footprint Global packaging leader TricorBraun has acquired Perth-based Plas-Pak WA, a plastic packaging distributor and manufacturer
  4. dsm-firmenich awards Nutrition Research Grants totalling €250,000 to APAC-based gut health researchers The nutrition-focused company will award up to €50,000 to each recipient to advance research on pre-, pro- and postbiotics, as well as human milk oligosaccharides (HMOs) on gut health and overall wellness
  5. Nutraceuticals: a major revenue opportunity for pharma companies There isn’t a single industry that hasn’t been affected by global economic disruptions in recent years. When searching for new revenue opportunities to mitigate these effects, many pharmaceutical companies are turning to nutraceuticals, reports Matevž Ambrožič, Marketing and PR Director at PharmaLinea

Upcoming event

Vitafoods India

5–7 February 2025 | Exhibition | Mumbai See all

You may also like

Training & Education

dsm-firmenich awards Nutrition Research Grants totalling €250,000 to APAC-based gut health researchers

The nutrition-focused company will award up to €50,000 to each recipient to advance research on pre-, pro- and postbiotics, as well as human milk oligosaccharides (HMOs) on gut health and overall wellness
Regulatory

Dr. Anju Majeed welcomes Maldivian president at the India-Maldives Business Forum

Forum aims to strengthen bilateral ties and explore investment opportunities
Distribution

CV Sciences acquires premium cannabinoid producer and distributor, Extract Labs

Extract Labs' range of nutraceuticals suitable for both B2B and B2C customers will bolster CV Science's product range, which include plant-based ingredients and functional foods
Manufacturing

Happy Plant Protein secures €1.8m to develop and license its plant-based protein ingredients

The manufacturing process developed by Happy Plant Protein can reduce plant-based protein production costs by up to 90%, while also creating functional food products with a 70–80% protein content
Finance

Arla Foods Ingredients one step closer to getting the Volac acquisition go-ahead

This follows the UK Competition and Market Authority's approval of Arla's acquisition of Volac's whey nutrition business
Ingredients

Miura Partners becomes the majority shareholder of HealthTech BioActives

The nutraceutical specialist will now be able to grow its functional health, taste modulation and animal nutrition divisions
Ingredients

OmniActive acquires functional ingredients specialist, ENovate Biolife

The purchase will bolster OmniActive's range of botanical nutraceuticals for active nutrition, joint health, heart health and men's wellness
Subscribe now